Pharma and Biotech Contracts in the 2026 Legal Order MasterClass - EU edition

Daniel Gamalski, PhD is an attorney-at-law and doctor of laws with more than 25 years experience in commercial law across the pharmaceutical, biotechnology and healthcare sectors, gained in an international environment. He heads the Life Sciences, Healthcare & Products practice at NGL Legal, advising at every stage of the product lifecycle.

For nearly fifteen years he was part of what is arguably the largest biotechnology undertaking in Central and Eastern Europe. There he built the legal and compliance function from the ground up and served on the operational management team and the risk management committee. He negotiated global licensing, supply and manufacturing agreements of multi-million-euro contribution, led cross-border M&A transactions, coordinated proceedings under the US Biologics Price Competition and Innovation Act (BPCIA), and ran group-level reorganisations. He held legal responsibility for the construction and GMP qualification of large-scale biologics manufacturing facilities and supported FDA and EMA inspections. His research and policy work addresses comparative international contract law associated with pharma operations, supply chains for pharmaceuticals as well as health-system crisis preparedness - at the intersection of law, industrial policy and national security.

He is a graduate in law of the University of Warsaw (commercial law, 2002) and holds a PhD from the University of Gdańsk (commercial law and private international law, 2009), together with a postgraduate qualification in teaching methodology. He has taught for many years in parallel with his in-house practice - commercial law, company law and the law of contract - using his own method built on the analysis of real contractual structures, negotiation simulations and case studies. Member of the Polish Association of Individual Investors, the Allerhand Institute and the InSELT Institute for Strategic Governance.

Michał Resmer is an attorney-at-law (radca prawny) specialising in intellectual property protection, with a particular focus on trademark law. For over 10 years, he gained extensive experience at one of Polands leading IP law firms, advising clients on trademark and industrial design registrations, conducting contentious proceedings, and representing clients in court litigation concerning infringements of exclusive rights.

He then spent nearly 5 years within the TMIC team at the Warsaw office of an international law firm, where he continued to advance his expertise in intellectual property law. During this period, he also completed an 8-month secondment with the in-house legal team of a global media and telecommunications company. He possesses rich, practical experience in conducting comprehensive trademark availability searches, managing registration and contentious proceedings before IP offices (national
IP offices, EUIPO, WIPO), as well as successfully negotiating coexistence agreements and settlements.

In his practice, Michał focuses on implementing strategic mechanisms and solutions that enable entrepreneurs to effectively safeguard their intellectual property and proactively prepare for potential acts of unfair competition. He works closely with clients from the creative industries, whose market position heavily relies on the effective protection of industrial property rights and copyright. Over the years, he has successfully advised both domestic and international companies operating in the energy, IT, gaming, pharmaceutical, luxury goods, automotive, and space sectors.